| Small-molecule ferroptotic agents with potential to selectively target cancer stem cells WR Taylor, SR Fedorka, I Gad, R Shah, HD Alqahtani, R Koranne, ... Scientific reports 9 (1), 5926, 2019 | 56 | 2019 |
| Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F N Kuganesan, S Dlamini, LMV Tillekeratne, WR Taylor Journal of Biological Chemistry 297 (6), 2021 | 40 | 2021 |
| Tunable cysteine-targeting electrophilic heteroaromatic warheads induce ferroptosis E Karaj, SH Sindi, N Kuganesan, L Perera, W Taylor, LMV Tillekeratne Journal of medicinal chemistry 65 (17), 11788-11817, 2022 | 18 | 2022 |
| Identification and initial characterization of a potent inhibitor of ferroptosis N Kuganesan, S Dlamini, J McDaniel, VLM Tillekeratne, WR Taylor Journal of cellular biochemistry 122 (3-4), 413-424, 2021 | 13 | 2021 |
| First-in-class dual mechanism ferroptosis-HDAC inhibitor hybrids E Karaj, SH Sindi, N Kuganesan, RA Koranne, JR Knoff, AW James, Y Fu, ... Journal of medicinal chemistry 65 (21), 14764-14791, 2022 | 7 | 2022 |
| Rational design of metabolically stable HDAC inhibitors: An overhaul of trifluoromethyl ketones B Riddhidev, K Endri, L Sabitri, L N Kotsull, K Nishanth, I Dragan, ... European journal of medicinal chemistry 244, 114807, 2022 | 4 | 2022 |
| Regulation of ferroptosis by transcription factor E2F1 and RB N Kuganesan, S Dlamini, VLM Tillekeratne, WR Taylor Research Square, 2023 | 2 | 2023 |
| Modulation of Ferroptosis by the Classical p53/p21/CDK/RB/E2F Pathway N Kuganesan The University of Toledo, 2023 | | 2023 |
| Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F N Kuganesan, S Dlamini, V Tillekeratne, W Taylor Journal of Biological Chemistry 299 (3), S496, 2023 | | 2023 |
Samkeliso DlaminiGraduate Student, University of ToledoVerified email at rockets.utoledo.edu
